Gennex Laboratories Limited (BOM:531739)
India
· Delayed Price · Currency is INR 10.32
+0.02 (0.19%)
At close: Apr 28, 2026
Gennex Laboratories Revenue
Gennex Laboratories had revenue of 403.66M INR in the quarter ending December 31, 2025, with 7.05% growth. This brings the company's revenue in the last twelve months to 1.52B, up 16.04% year-over-year. In the fiscal year ending March 31, 2025, Gennex Laboratories had annual revenue of 1.38B with 59.03% growth.
Revenue (ttm)
1.52B
Revenue Growth
+16.04%
P/S Ratio
1.65
Revenue / Employee
13.23M
Employees
115
Market Cap
2.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.38B | 511.89M | 59.03% |
| Mar 31, 2024 | 867.14M | 211.11M | 32.18% |
| Mar 31, 2023 | 656.03M | 43.89M | 7.17% |
| Mar 31, 2022 | 612.14M | 15.65M | 2.62% |
| Mar 31, 2021 | 596.49M | 34.18M | 6.08% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambalal Sarabhai Enterprises | 2.03B |
| Everest Organics | 1.89B |
| Kerala Ayurveda | 1.27B |
| Trident Lifeline | 1.27B |
| BDH Industries | 847.44M |
| Oxygenta Pharmaceutical | 1.13B |
| Sanjivani Paranteral | 736.34M |
| Sat Kartar Life | 1.63B |